1.Aberrant CD3 Expression in a Relapsed Plasma Cell Neoplasm
Journal of Pathology and Translational Medicine 2018;52(3):202-205
No abstract available.
Neoplasms, Plasma Cell
;
Plasma Cells
;
Plasma
2.Nodal involvement of extranodal marginal zone lymphoma with extreme plasmacytic differentiation (Mott cell formation) simulating plasma cell neoplasm and lymphoplasmacytic lymphoma.
Yosep CHONG ; Chang Suk KANG ; Woo Jin OH ; Tae Jung KIM ; Eun Jung LEE
Blood Research 2014;49(4):275-285
No abstract available.
Lymphoma*
;
Neoplasms, Plasma Cell*
3.Crystal-Storing Histiocytosis with Plasma Cell Neoplasm in the Setting of Chronic Carbamazepine Exposure
Woo Cheal CHO ; Safina HAFEEZ ; Peter SHEN
Journal of Pathology and Translational Medicine 2019;53(2):142-144
No abstract available.
Carbamazepine
;
Histiocytosis
;
Neoplasms, Plasma Cell
;
Plasma Cells
;
Plasma
6.SOLITARY PLASMA CELL MYELOMA ON ANTERIOR MAXILLA: A CASE REPORT
Ji A JEONG ; Go Eun SEO ; Jun Ho SONG ; Sang Jun PARK
Journal of the Korean Association of Maxillofacial Plastic and Reconstructive Surgeons 2010;32(1):77-80
Plasma cell myeloma is malignant disease of plasma cell in the bone marrow. Myeloma accounts for about 1% of all cancers. The solitary plasma cellmyeloma is rare tumors and account for less than 10% of plasma cell neoplasm. It is often progress to multiple myeloma at 30-40% despite successful local treatment with surgery and radiation therapy. We are reporting a case of solitary plasma cell myeloma on anterior maxillary region that developed after kidney transplantation and immunosuppressive therapy.]]>
Bone Marrow
;
Kidney Transplantation
;
Maxilla
;
Multiple Myeloma
;
Neoplasms, Plasma Cell
;
Plasma
;
Plasma Cells
7.Multiple myeloma in the mandible manifested as oral lesion of plasmacytoma: a Case Report
Jeong A LEE ; Ji Young PARK ; Sung Hun YUN ; Min Kyu PARK ; Chang Hyun KIM ; Je Uk PARK
Journal of the Korean Association of Maxillofacial Plastic and Reconstructive Surgeons 2007;29(1):85-90
Plasma cell neoplasms are generally categorized into four groups; multiple myeloma(MM), solitary plasmacytoma of the bone(SPB), plasma cell leukemias, and extramedullary plasmacytomas(EMP). These tumors may be further described as localized or diffuse in presentation. Localized plasma cell neoplasms are rare occurrences and include solitary plasmacytomas of the skeletal system, which account for 2-5% of all plasma cell neoplasms and extramedullary plasmacytomas of the soft tissue, which account for approximately 3% of all such neoplasms. A plasmacytoma is defined as any discrete, most likely solitary mass of neoplastic plasma cells either in the bone marrow or in various soft tissue sites. Diffuse lesions include the other two groups, multiple myeloma and plasma cell leukemia. The relationship between these processes has not yet been definitively characterized, but there appears to be a continuum in which both SPB and EMP often progress to MM. The patient was referred who had continuous deep throbbing bone pain and swelling on the left posterior gingival area of the mandible after extraction of the first and second molar. The result of intraoperative excisional biopsy of the lesion was confirmed as a plasmacytoma. And it revealed systemic multiple myeloma through the further diagnostic work-up. It is worth to report because of a rare case of multiple myeloma found in oral cavity as a form of plasmacytoma.]]>
Biopsy
;
Bone Marrow
;
Humans
;
Leukemia, Plasma Cell
;
Mandible
;
Molar
;
Mouth
;
Multiple Myeloma
;
Neoplasms, Plasma Cell
;
Plasma Cells
;
Plasmacytoma
8.Malignant inflammatory myofibroblastic tumor of the left mandible: a case report.
Di LÜ ; Yu CHEN ; Mingzhong YANG ; Hong LIU
West China Journal of Stomatology 2011;29(5):562-564
A case of malignant inflammatory myofibroblastic tumor was reported. The relevant literatures were reviewed to discuss the clinical and pathologic characteristics, diagnosis and therapy of malignant inflammatory myofibroblastic tumor.
Granuloma, Plasma Cell
;
Humans
;
Mandible
;
Neoplasms, Muscle Tissue
9.Platelet-rich plasma injection of skin graft in a patient with squamous cell carcinoma and psoriasis on prolonged methotrexate therapy: A case report
Florteresa G. Ollero ; Patricia Cleopatra Geluz Guieb ; Maria Cristina A. Puyat ; Maria Isabel Beatriz Puno-Gomez ; Erika Kim Chan
Journal of the Philippine Medical Association 2022;101(1):79-83
Introduction:
Psoriasis and some of its treatments such as methotrexate have been linked to the development of non-melanoma skin cancers including cutaneous squamous cell carcinoma (SCC). Chronic maque psoriasis, Koebnerization, and prolonged methotrexate therapy are some of the concerns that may impact wound healing and graft uptake when treating these patients.
Case Report:
We report a case of a 64-year-old male with a 32-year history of moderate to severe psoriasis continuously self-medicating with methotrexate for 30 years who presented with a solitary indurated tumor with ulceration on the right anterior leg. Histopathology result revealed acantholytic cSCC.
The patient
concomitantly has generalized psoriatic plaques that complicated the selection of donor site for the skin graft, and raised concerns on wound healing and graft uptake.
He underwent wide excision surgery with gastrocnemius (medial head) flap and split thickness skin graft. Platelet-rich plasma (PRP) injections were utilized post-operatively to increase graft survival and donor site regeneration.
Discussion
The main risk factors for the development of cSCC for this patient are the history of chronic plaque psoriasis and chronic methotrexate therapy. These two can also complicate the success of grafting and wound healing for this patient. PRP was utilized to for better graft survival, faster wound healing, and prevention of Koebnerization.
Platelet-Rich Plasma
;
Neoplasms, Squamous Cell
;
Psoriasis
;
Methotrexate
10.Solitary Plasmacytoma of the Sternum.
Jung Hwa LEE ; Woo Surng LEE ; Yo Han KIM ; Jong Duk KIM
The Korean Journal of Thoracic and Cardiovascular Surgery 2013;46(6):482-485
Plasmacytoma is a plasma cell neoplasm that locally infiltrates a bone or spreads to extramedullary areas. A new World Health Organization criterion defines solitary plasmacytoma of bone as a localized bone tumor consisting of plasma cells identical to those seen in plasma cell myeloma, which is manifested as a solitary osteolytic lesion in a radiological evaluation. Primary tumors of the sternum are generally malignant, and solitary plasmacytomas of the sternum are very rare tumors. We present herein the case of a patient who had a primary sternal tumor with solitary plasmacytoma and no evidence of multiple myeloma.
Humans
;
Multiple Myeloma
;
Neoplasms, Plasma Cell
;
Plasma Cells
;
Plasmacytoma*
;
Sternum*
;
World Health Organization